UBS Reiterates InterContinental Hotels Group (ICHGF) Buy Recommendation

UBS reiterated a "Buy" recommendation for InterContinental Hotels Group (OTCPK:ICHGF), setting an average one-year price target of $121.34, which suggests a 22.87% upside from its latest closing price of $98.75. This positive analyst outlook is presented despite a projected annual revenue decrease of 46.54% to $2,737 million and an anticipated non-GAAP EPS of $3.84. Institutional ownership data indicates a slight decrease in the number of funds holding ICHGF and total shares owned, yet the average portfolio weight dedicated to the stock increased by 3.85%, reflecting a nuanced and somewhat mixed institutional sentiment.

Analysis

UBS reiterated a "Buy" recommendation for InterContinental Hotels Group (ICHGF) on October 17, 2025, setting an average one-year price target of $121.34. This target suggests a substantial 22.87% upside from the latest reported closing price of $98.75, reflecting a strong positive outlook from the analyst.

However, this bullish analyst stance is juxtaposed with challenging financial projections, as the company's annual revenue is forecast to decrease significantly by 46.54% to $2,737 million. The projected annual non-GAAP EPS is $3.84, which must be evaluated in the context of this substantial revenue contraction.

Institutional sentiment appears mixed; while the number of funds holding ICHGF decreased by 2.62% and total institutional shares owned declined by 11.47% to 30,110K shares, the average portfolio weight of funds dedicated to ICHGF increased by 3.85%. This indicates that while some institutions are divesting, others are increasing their conviction.

Specific fund activity further highlights this divergence, with AEPGX increasing its stake and allocation, while major funds like VGTSX and VTMGX significantly reduced their shareholdings and portfolio allocations in ICHGF. This varied institutional positioning suggests differing views on the company's future prospects.

Key Decisions for Investors

• Investors should critically assess the disconnect between UBS's "Buy" rating and 22.87% price target upside against the projected 46.54% decline in annual revenue.
• Further due diligence is warranted to understand the specific drivers of the significant revenue contraction and whether the current market valuation fully incorporates this negative financial outlook.
• Monitor future institutional ownership filings and earnings reports for clearer directional signals, particularly observing if the average portfolio weight increase persists or if overall institutional divestment accelerates.